Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
As of Mar. 2026, Mettler-Toledo International has a Sloan Ratio of 5.20%, indicating the company is in the safe zone and there is no funny business with accruals.
Mettler-Toledo International (FRA:MTO) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Mar. 2026, Mettler-Toledo International has a Sloan Ratio of 5.20%, indicating the company is in the safe zone and there is no funny business with accruals.
Mettler-Toledo International Sloan Ratio % Related Terms
Mettler-Toledo International Sloan Ratio % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MTO vs DGX, LH, ILMN: Sloan Ratio % Comparison
For the Diagnostics & Research subindustry, Mettler-Toledo International's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mettler-Toledo International Sloan Ratio % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Mettler-Toledo International's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Mettler-Toledo International's Sloan Ratio % falls into.
Mettler-Toledo International Sloan Ratio % Calculation
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Mettler-Toledo International's Net Income for the trailing twelve months (TTM) ended in Mar. 2026 was 175.436 (Jun. 2025 ) + 185.304 (Sep. 2025 ) + 244.043 (Dec. 2025 ) + 146.578 (Mar. 2026 ) = €751 Mil.
Mettler-Toledo International's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was 204.929 (Jun. 2025 ) + 255.065 (Sep. 2025 ) + 192.65 (Dec. 2025 ) + 120.922 (Mar. 2026 ) = €774 Mil.
Mettler-Toledo International's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2026 was -41.313 (Jun. 2025 ) + -84.273 (Sep. 2025 ) + -34.506 (Dec. 2025 ) + -27.116 (Mar. 2026 ) = €-187 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mettler-Toledo International (FRA:MTO) has a Sloan Ratio % of 5.20% as of Mar. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Mettler-Toledo International and its competitors.
Is Mettler-Toledo International's Sloan Ratio % too high?
Mettler-Toledo International's current Sloan Ratio % is 5.20%. Overall, Mettler-Toledo International has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Mettler-Toledo International's Sloan Ratio % compare to DGX and LH?
Mettler-Toledo International's Sloan Ratio % of 5.20% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Medical Diagnostics & Research company?
A good Sloan Ratio % depends on the Medical Diagnostics & Research industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Mettler-Toledo International and its competitors. Mettler-Toledo International's current Sloan Ratio % is 5.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mettler-Toledo International stock overvalued right now?
Mettler-Toledo International (FRA:MTO) has a current Sloan Ratio % of 5.20%. The stock's GF Value™ is €1,263.21, compared to a current price of €1,166.00 — trading 7.7% below its estimated fair value. The current Sloan Ratio % is 5.20%. Mettler-Toledo International's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Mettler-Toledo International (FRA:MTO), the current Sloan Ratio % is 5.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mettler-Toledo International (FRA:MTO) Overvalued in 2026?
Based on GuruFocus' analysis, Mettler-Toledo International stock appears to be undervalued.
The current stock price of €1,166.00 is trading 7.7% below its estimated GF Value™ of €1,263.21.
Key valuation signals for FRA:MTO:
Sloan Ratio %: 5.20%
GF Value™: €1,263.21 vs. price of €1,166.00 (7.7% below fair value)
No single metric tells the full story. See the FRA:MTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.
92GF Score
Get the complete analysis for FRA:MTO
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MTO has been successfully added to your 
